Drug Monograph Updates
The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of June. The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com. Key: D=Dosing,…
Baricitinib 1mg, 2mg, 4mg; tabs.
The approval was based on data from the phase 2/3 BRAVE-AA1 and phase 3 BRAVE-AA2 trials, which included adults with severe alopecia areata.
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.